Primary Country (Mandatory)

Other Country (Optional)

Set News Language for United States

Primary Language (Mandatory)
Other Language[s] (Optional)
No other language available

Set News Language for World

Primary Language (Mandatory)
Other Language(s) (Optional)

Set News Source for United States

Primary Source (Mandatory)
Other Source[s] (Optional)

Set News Source for World

Primary Source (Mandatory)
Other Source(s) (Optional)
  • Countries
    • India
    • United States
    • Qatar
    • Germany
    • China
    • Canada
    • World
  • Categories
    • National
    • International
    • Business
    • Entertainment
    • Sports
    • Special
    • All Categories
  • Available Languages for United States
    • English
  • All Languages
    • English
    • Hindi
    • Arabic
    • German
    • Chinese
    • French
  • Sources
    • India
      • AajTak
      • NDTV India
      • The Hindu
      • India Today
      • Zee News
      • NDTV
      • BBC
      • The Wire
      • News18
      • News 24
      • The Quint
      • ABP News
      • Zee News
      • News 24
    • United States
      • CNN
      • Fox News
      • Al Jazeera
      • CBSN
      • NY Post
      • Voice of America
      • The New York Times
      • HuffPost
      • ABC News
      • Newsy
    • Qatar
      • Al Jazeera
      • Al Arab
      • The Peninsula
      • Gulf Times
      • Al Sharq
      • Qatar Tribune
      • Al Raya
      • Lusail
    • Germany
      • DW
      • ZDF
      • ProSieben
      • RTL
      • n-tv
      • Die Welt
      • Süddeutsche Zeitung
      • Frankfurter Rundschau
    • China
      • China Daily
      • BBC
      • The New York Times
      • Voice of America
      • Beijing Daily
      • The Epoch Times
      • Ta Kung Pao
      • Xinmin Evening News
    • Canada
      • CBC
      • Radio-Canada
      • CTV
      • TVA Nouvelles
      • Le Journal de Montréal
      • Global News
      • BNN Bloomberg
      • Métro
How does Pfizer's COVID-19 pill work and who will get it?

How does Pfizer's COVID-19 pill work and who will get it?

CBC
Tuesday, January 25, 2022 12:37:34 PM UTC

This story idea came from audience members, like you, who got in touch with us. Send us all of your questions about COVID-19. We are listening: ask@cbc.ca.

Now that Health Canada has approved Pfizer's COVID-19 therapeutic Paxlovid for use in people 18 and older, CBC News has been receiving questions about how it works and what its limitations are.

For starters, it's an oral antiviral treatment. In other words, pills that help you fight off the symptoms of COVID-19.

But here's a closer look at the ins and outs of the treatment.

Paxlovid consists of two antiviral drugs packaged together: nirmatrelvir and ritonavir. 

Patients take three pills twice a day: two of nirmatrelvir and one of ritonavir. In total, the full course of treatment requires you take 30 pills over the span of five days.

Nirmatrelvir is a new drug developed by Pfizer-BioNTech, while ritonavir is an existing drug often used in the treatment of HIV/AIDS.

The two drugs work together, health experts say. Nirmatrelvir does the heavy lifting by hacking the virus's ability to replicate and multiply, while ritonavir acts as a sidekick to nirmatrelvir, enabling it to remain in the body longer. 

Paxlovid is something called a protease inhibitor, explained Dr. Isaac Bogoch, an infectious diseases specialist at Toronto General Hospital.

"It stops the virus from dividing by blocking a part of its life cycle," he said, noting this allows your immune system to fight off the virus a lot easier.

But it's crucial to start treatment soon after infection, Bogoch said, "to really nip it in the bud early." 

According to immunologist Dr. David Burt, who is also a member of Toronto's Black Scientists' Task Force on Vaccine Equity, the only drawback with these types of treatments is a "very narrow window of opportunity" before the drug loses its effectiveness.

When taken within five days of infection, Pfizer's clinical trials showed that the drug reduced risk of hospitalization or death by 85 per cent.

Canadians will need a prescription to get Paxlovid, according to Health Canada.

Read full story on CBC
Share this story on:-
More Related News
Children’s hospitals in Canada face flood of flu visits as doctors urge families to get vaccinated

An early start to Canada’s flu season is hitting children hard, sending a flood of young patients into multiple pediatric hospitals as medical teams warn that emergency visits and admissions could keep climbing in the weeks ahead.

Building better homes key to fixing Indigenous housing crisis, says report

Energy efficient homes are key to improving some health issues and solving the housing crisis in Indigenous communities, according to a new report on Indigenous housing.

Launching hundreds of thousands of satellites will threaten space research, scientists warn

Satellite constellations, networks of multiple satellites that can number from a few dozen to tens of thousands, are interfering with scientific research using ground-based telescopes, but now a new study looks at how they might affect space-bound telescopes like Hubble.

New research suggests surge in incurable prostate cancer from lack of early screening

A surge in the rate of incurable prostate cancer cases could be a sign to rethink Canada’s stance on screening for one of the most common diseases for men, according to new research. 

RCMP restricts use of Chinese-made drones — the vast majority of its fleet

The Royal Canadian Mounted Police is limiting the use of its 973 Chinese-made drones to non-sensitive operations, stating the devices present "high security risks, primarily due to their country of origin."

New data shows RSV shots prevent ‘most dangerous’ respiratory infection for newborns

As Katrina Bellavance’s seven-week-old daughter kept coughing non-stop, the Calgary mother unzipped her newborn’s pajamas and saw the skin around her tiny ribs tugging inward with each laboured breath. 

Assembly of First Nations says major projects office, infrastructure on meeting agenda

Assembly of First Nations chiefs are gathering this week in Ottawa for their annual December meeting, which will include discussions on the federal government’s major projects office and the urgent need for First Nations infrastructure, the AFN says.

B.C. bitcoin mines are transitioning into AI data centres

The company behind three major data centres in northern B.C. and the Kootenays is making a big shift. 

As women with ‘invisible illnesses’ struggle to be believed, a report on chronic pain could help

Medical professionals say a 2021 report supported by Health Canada could have a major impact on how the medical system can better understand chronic pain and the best ways to diagnose it — something that has been considered a major weakness in health care up to this point.  

These Wabanaki artifacts at UNB have sparked archeological collaboration and innovation

In a quiet room in the University of New Brunswick's library, Ramona Nicholas gives a small laugh when asked what it's like to be part of an archeological project involving her ancestors.

After 10 years of delay, the controversial Thirty Meter Telescope may finally get built — in Spain

A long-delayed project to build the largest telescope in the Northern Hemisphere atop Mauna Kea in Hawaii has been given new life, as Spain has offered new funding and a new location on the island of La Palma.

Flu vaccines take months to make. Here's what could speed it up

This story is part of CBC Health's Second Opinion, a weekly analysis of health and medical science news emailed to subscribers on Saturday mornings. If you haven't subscribed yet, you can do that by clicking here.

© 2008 - 2025 Webjosh  |  News Archive  |  Privacy Policy  |  Contact Us